Coeptis Therapeutics is merging with Z Squared, a Dogecoin mining company, aiming to become the largest publicly traded Dogecoin miner. Following the announcement, shares of Coeptis fell by nearly 40%, reflecting shareholder skepticism regarding the company's shift away from biopharmaceuticals. Z Squared's CEO stated the merger represents an opportunity for exposure to the Dogecoin market, which has a market cap exceeding $20 billion. Despite the price drop, shares are still up 37% year-to-date but significantly down from their all-time high. Coeptis will continue its biopharmaceutical operations while also focusing on Dogecoin and Litecoin mining. The firms are awaiting regulatory and shareholder approvals to finalize the merger, indicating a potentially significant shift in Coeptis's business model towards cryptocurrency.

Source 🔗